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1. Introduction 2. Materials and methods 
Fibronectin is a class of adhesive glycoproteins 
present at the cell surface, intercellular matrices, 
plasma nd other body fluids, sharing properties such 
as: 
(1) A high M r (>400 000) consisting of 2 disulfide- 
linked subunits ot and/3, though these subunits 
may or may not be identical; 
(2) Binding to collagen, heparin and fibrin, and 
inducing cell adhesion and spreading (reviews 
[1-41). 
The functional domains having these binding activities 
have been isolated and characterized [5,6]. The dele- 
tion of fibronectin from the cell surface, associated 
with oncogenic transformation [7,8], may be related 
to a decreased adhesiveness and increased invasive 
properties of cancer cells [9,10]. Polyclonal antibodies 
directed to fibronectin are cross-reactive irrespective 
of their sources and species [1-4] and have been 
used as a reagent to detect and quantify fibronectin 
or its related compounds. We now report wo mono- 
clonal antibodies directed respectively to the collagen- 
binding domain and to the domain which binds to 
heparin and induces cell adhesion and spreading. While 
this work was in progress, papers describing mono- 
clonal antibodies directed to fibronectin have been 
published [ 11-14], although the specificities of anti- 
bodies described are entirely different from those 
reported here. 
* To whom correspondence should be addressed 
Abbreviation: PBS, phosphate-buffered saline, 137 mM NaC1, 
2.7 mM KCI, 8.1 mM Na2HPO4, 1.5 mM KH2PO s (pH 7.4) 
2.1. Purification of  fibronectin and its proteolytic 
fragments 
Plasma fibronectins of various pecies were purified 
by affinity chromatography on gelatin-Sepharose as 
in [5,6]. Cellular fibronectin purified from condi- 
tioned medium of WI-3 8 human fibroblasts was kindly 
provided by Dr W. G. Carter. Cell-surface fibronectin 
of chick embryo fibroblasts was isolated as in [ 15]. 
The domain fragments of human plasma fibronectin 
were isolated after thermolysin digestion as in [6]. 
2.2. Production of  hybridomas 
Hybridomas producing monoclonal ntibodies 
were prepared as in [16]. Balb/c mice were immu- 
nized with human plasma fibronectin in complete 
Freund's adjuvant. The antigen solution contained 
3.5 mg fibronectin/ml, and 75-100/A were injected/ 
mouse. Four subcutaneous injections were performed 
at 10-day intervals. Cell fusion with the mouse mye- 
loma NS/1 was performed 3 days after the last immu- 
nization. Hybrids producing antibodies were screened 
and minicloned in microtiter wells as in [17,18]. Two 
hybridoma clones were isolated; these are called D5 
and H5, respectively. Immunoglobulin class of these 
antibodies was determined with rabbit antisera spe- 
cific for various mouse immunoglobulin classes (Litton 
Bionetics, Kensington, MD 20795) according to [ 19]. 
2.3. Determination of  the antibody specificity 
The affinity of antibodies to fibronectins from dif- 
ferent species was tested by solid-phase competitive 
radioimmunoassay as in fig.1. The blocking activity 
of the antibodies for gelatin-binding and cell attach- 
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ment mediated by fibronectin has been tested as fol- 
lows: Plastic plates (Dynatech/'Microelisa pl tes') 
were first coated with fibronectin by incubating for 
2 h with a solution of fibronectin in PBS containing 
10 #g/ml. The plates were then blocked by incubating 
for 2 h with 5% bovine serum albumin in PBS. The 
plates were washed 3 times with PBS and incubated 
with the antibodies for 45 rain, followed by the addi- 
tion of the 12SI-labeled gelatin or NIL cells metaboli- 
cally labeled with [aH]leucine. The inhibitory effect 
of antibodies can be observed by the decrease of 
radioactivity bound to the fibronectin coat. The reac- 
tivity of fibronectin fragments to antibodies was 
tested on polyacrylamide g l electrophoresis followed 
by transferring onto a nitrocellulose sheet and react- 
ing with antibodies [20]. 
3.  Resu l t s  
3.1. Two hybridoma lines, producing IgG ~ antibodies, 
specific for human fibronectin 
Two hybridoma cell lines, D5 and H5, were estab- 
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Fig.1. The affinities of H5 (A) and D5 (B) antibodies for 
fibronectins ofvarious pecies. Polystyrene microtiter plates 
were coated with either 1 ~g/ml (for H5) or 0.1 #g/ml (for 
D5) of human fibronectin and then incubated with 5% bovine 
serum albumin. The plates were washed with PBS then incu- 
bated with antibodies towhich were added serially-diluted 
fibronectins from different species. The plates were washed 
and then incubated sequentially with rabbit anti-mouse 
immunoglobulin a d 12s I-labeled protein A: (o) human 
plasma fibronectin; (o) human cellular fibronectin; (z~) fibro- 
nectin from fetal bovine serum; (A) fibronectin from new- 
born bovine serum; (u) guinea pig plasma fibronectin; (o) 
chicken cellular fibronectin; (v) mouse plasma fibronectin. 
lished and characterized to produce IgGl antibodies. 
These antibodies seem to be specific to human fibro- 
nectin, because they reacted strongly with both 
human plasma nd cellular fibronectin but not with 
fibronectin from bovine, guinea pig, mouse or chicken 
(fig.l). 
3.2. Domain specificity of two hybridoma ntibodies 
The specificity of two hybridoma ntibodies in 
their reactivity to different domains isolated after pro- 
teolysis was determined first by plate assay [17,18]. 
The antibody produced by the hybridoma D5 reacted 
specifically with the gelatin-binding domain with 
40 000 M r. In contrast, the antibody produced by the 
hybridoma H5 reacted specifically with the 150 000-  
140 000 M r fragment which represents he domain 
capable of binding to heparin and inducing cell attach- 
ment and spreading. These results were further con- 
firmed by gel electrophoresis of proteolytic digests of 
fibronectin followed by transferring onto nitrocellu- 
lose membrane and reacting with antibodies. Among 
4 different domain fragments produced by thermolysin 
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Fig.2. Domain specificity of H5 and D5 monoclonal nti- 
bodies. Human plasma fibronectin was digested at room tem- 
perature by either trypsin (1 ~g/ml, 30 rain) or thermolysin 
(5 #g/ml, 4 h). The digests were analyzed on SDS-polyacryl- 
amide gel electrophoresis in triplicate. One group was stained 
by Coomassie blue (left). The other two groups were blotted 
on nitrocellulose and incubated with H5 (middle) and D5 
(right), followed by sequential incubation with rabbit anti- 
mouse immunoglobulin a d t2s I-labeled protein A: (a) intact 
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Fig.3. Inhibition of the binding of 12s I-labeled gelatin on 
fibronectin-coated plate. Fibronectin-coated plate was incu- 
bated with H5 (e) or D5 (o) ascites in serial dilutions, then 
incubated with l=5l-labeled gelatin. 
fragments, whereas D5 only reacted with 40 000M r 
fragment (fig.2c). Similarly, tryptic 200 000 and 
180 000 M r fragments which contain both 150 000-  
140 000 and 40 000 M r domains were also heavily 
stained by both H5 and D5 (fig.2b). 
3.3. Antibody blocking of gelatin-binding and cell 
attachment 
The antibody specific to gelatin-binding domain 
(D5) was found to block the binding of radioactive 
gelatin on the fibronectin-coated plate, whereas the 
antibody directed to cell-binding domain (H5) d id  
not block the binding of radioactive gelatin on the 
fibronectin layer (fig.3). 
The effect of monoclonal antibodies on the fibro- 
nectin-mediated cell attachment was studied on fibro- 
nectin-coated plates with or without he addition of the 
monoclonal antibodies (table 1). There was no prefer- 
Table 1 
Effect of monoclonal ntibodies on the FN-mediated cell 
attachment 
Substrate Antibody (ascites a) Cell attachment 
(cpm) 
Human FN None 4.174 (100%) 
Human FN Anti-150 000- 3.606 (86%) 
140 O00M r (H5) 
Human FN Anti-40 00M r (DS) 3.610 (86%) 
Human FN Anti-mouse H-2D 3.932 (94%) 
BSA None 0.171 (4%) 
Hamster FN None 4.022 (96%) 
a Dilution of ascites: X10 
ential inhibition of cell attachment by either anti- 
body directed to 150 000-140 000 M r or 40 000 M r 
domain. 
4. Discussion 
Because of their narrow specificities, monoclonal 
antibodies can be used as probes to pinpoint a spe- 
cific region of a protein. Since fibronectin has been 
shown to consist of at least 4 distinct functional 
domains [6], monoclonal antibody specific to each 
domain is a powerful tool for the detailed analysis of 
its structure-function relationship. We produced two 
such antibodies against human plasma fibronectin 
with different domain specificities. One of them, D5, 
is directed to 40 000M r gelatin-binding domain and 
the other, H5, is directed to 150 000-140 000 M r 
domain. D5 inhibits the interaction of gelatin with 
fibronectin. Interestingly, H5 did not interfere with 
fibronectin-mediated c llattachment although poly- 
clonal anti-fibronectin antibodies generally inhibit 
fibronectin-mediated c llattachment [21]. In [14], a 
monoclonal antibody directed to the small locus of 
cell adhesion site of fibronectin blocked cell adhesion 
and spreading. The small ocus represents a polypep- 
tide region of 15 000 M r that promotes cell adhe- 
sion and spreading. Therefore, H5 does not recognize 
the same locus or domain as recognized by the mono- 
clonal antibody in [14]. 
The majority of polyclonal antibodies prepared for 
any species of fibronectin are cross-reacted to fibro- 
nectins of different species although species-specific 
antibodies can be prepared by absorbing antibodies 
with fibronectins of certain species [22]. The anti- 
bodies reported here may be useful, because of their 
narrow species pecificity, to study the distribution of 
human fibronectin as injected in different species. The 
observation that the antibody directed to 40 000 M r 
domain (D5) did not inhibit cell attachment but 
inhibited binding of gelatin to fibronectin clearly 
indicates that cell attachment on fibronectin is differ- 
ent from the gelatin-binding property and is not 
mediated through this domain. 
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